CD40L, Human, HEK293 Cells,Tag Free

CD40 Ligand(CD40L),also known as TNFSF, CD154, TRAP, and gp39, is a 34-39 kDa type II transmembrane glycoprotein that belongs to the TNF superfamily

(1-3). Mature human CD40 Ligand consists of a 22 amino acid (aa) cytoplasmic domain, a transmembrane segment, and an 215 aa extracellular region (4, 5). The

extracellular domain of human CD40 Ligand shares 74% and 76% aa sequence identity with mouse and rat CD40 Ligand, respectively. Similar to other TNF superfamily members, CD40 Ligand forms a bioactive homotrimer, both as membrane bound and soluble forms (6-9). The 18 kDa soluble form (aa 113-261) arises from proteolytic processing. Mutation and alternative splicing generate additional forms of CD40 Ligand that are often truncated or non-trimerizable (8). CD40 Ligand is expressed on

platelets, as well as on activated T cells and B cells, basophils, eosinophils, fibroblasts, mast cells, monocytes, natural killer cells, vascular endothelial cells, and smooth

muscle cells. CD40 Ligand binds to CD40, which is expressed on the surface of B cells, dendritic cells, macrophages, monocytes, platelets, endothelial, and epithelial cells (10). The interaction of CD40 Ligand with CD40 initiates signaling in both CD40 and CD40 Ligand expressing cells (11).  CD40 ligation by CD40 Ligand promotes B cell activation and T cell-dependent humoral responses (12, 13). CD40 Ligand dysregulation on T cells and antigen presenting cells contributes to the immune deficiency

associated with HIV infection and AIDS (14, 15). It is also implicated in the pathology of multiple cardiovascular diseases including atherosclerosis, atherothrombosis, and restenosis (16, 17).

1. Zhang, G. (2004) Curr. Opin. Struct. Biol. 14:154.

2. Hehlgans, T. and K. Pfeffer (2005) Immunology 115:1.

3. Quezada, S.A. et al. (2004) Annu. Rev. Immunol. 22:307.

4. Graf, D. et al. (1992) Eur. J. Immunol. 22:3191.

5. Hollenbaugh, D. et al. (1992) EMBO J. 11:4313.

6. Khandekar, S.S. et al. (2001) Protein Expr. Purif. 23:301.

7. Pietravalle, F. et al. (1996) J. Biol. Chem. 271:5965.

8. Garber, E. et al. (1999) J. Biol. Chem. 274:33545.

9. Vakkalanka, R.K. et al. (1999) Arthritis Rheum. 42:871.

10. van Kooten, C. and J. Banchereau (1997) Curr. Opin. Immunol. 9:330.

11. Eissner, G. et al. (2004) Cytokine Growth Factor. Rev. 15:353.

12. Rickert, R.C. et al. (2011) Immunol. Rev. 244:115.

13. Elgueta, R. et al. (2009) Immunol. Rev. 229:152.

14. Kornbluth, R.S. (2000) J. Leukoc. Biol. 68:373.

15. Chougnet, C. (2003) J. Leukoc. Biol. 74:702.

16. Pamukcu, B. et al. (2011) Ann. Med. 43:331.

17. Hassan, G.S. et al. (2012) Immunobiology 217:521.